Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 3.98M | $45.0M | 4.15% | +1.08M | 2026-06-30 |
| Venrock Adviser, LLC | 3.21M | $36.0M | 3.35% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.06M | $35.0M | 3.20% | +2.18M | 2026-06-30 |
| Point72 Asset Management, L.P. | 2.14M | $24.0M | 2.24% | -- | 2026-06-30 |
| MPM BIOIMPACT LLC | 1.94M | $22.0M | 2.02% | -- | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 1.79M | $20.0M | 1.87% | -- | 2026-06-30 |
| Casdin Capital, LLC | 1.25M | $14.0M | 1.31% | +711.5K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 1.02M | $11.0M | 1.06% | +899.9K | 2026-06-30 |
| Octagon Capital Advisors LP | 934.7K | $10.0M | 0.98% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 807.8K | $9.0M | 0.84% | +126.1K | 2026-06-30 |
